drug

D Serine

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Nathan Kline Institute for Psychiatric Research
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Biomarkers in Schizophrenia
NCT00817336Phase 2Completed

KOLs & investigators

1
Daniel C. Javitt, MD, PhDKOL score 8

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Nathan Kline Institute for Psychiatric Research
company
trial
Biomarkers in Schizophrenia
PHASE2
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
Schizoaffective Disorder
indication
KOL
Daniel C. Javitt, MD, PhD
KOL score 8
person